HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
methyl-3-indolylacetate
structure in first source
Networked:
1
relevant articles (
0
outcomes,
1
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Indoles: 200
Indoleacetic Acids: 615
methyl-3-indolylacetate: 1
Heterocyclic Acids
Indoleacetic Acids: 615
methyl-3-indolylacetate: 1
Experts
1.
Huang, Qing
: 1 article (12/2006)
2.
Li, Zhi
: 1 article (12/2006)
3.
Ong, Choon-Nam
: 1 article (12/2006)
4.
Shen, Han-Ming
: 1 article (12/2006)
5.
Wu, Ximei
: 1 article (12/2006)
6.
Zhang, Siyuan
: 1 article (12/2006)
Related Diseases
1.
Neoplasms (Cancer)
12/01/2006 - "
Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/2-ERK1/2 signaling pathway.
"
12/01/2006 - "
In this study, methyl-3-indolylacetate (MIA), a cruciferous indole for which the bioactivity has not been previously reported, was found to significantly suppress the invasion of cancer cells stimulated by the 12-O-tetradecanoyl-phorbol-13-acetate (TPA).
"
Related Drugs and Biologics
1.
indole